US Stocks
/
Rapport Therapeutics, Inc. Share Price

Rapport Therapeutics, Inc. Share Price

NASDAQ: RAPP | Small Cap
$30.68
+$0.79 (2.63%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Rapport Therapeutics, Inc. Stock Performance

Open
$29.84
Prev. Close
$29.89
Circuit Range
N/A
Day Range
$29.68 - $31.18
Year Range
$24.23 - $52.93
Volume
14,691
Average Traded
$30.31

Rapport Therapeutics, Inc. Share Price Today

As of 10 October 2026, Rapport Therapeutics, Inc.'s share price is $30.68. The stock opened at $29.84, compared to its previous close of $29.89. During today's trading session, Rapport Therapeutics, Inc.'s share price traded between $29.68 and $31.18, with an average price of $30.43. Over the past 52 weeks, the stock has recorded a high of $52.93 and a low of $24.23. In terms of performance, Rapport Therapeutics, Inc.'s share price has declined by 7.49% over the last six months and is up 6.16% on a year-on-year basis.

Rapport Therapeutics, Inc. Share Price Chart

$29.68$31.18
L
Show Current Price
H

Rapport Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.19B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.86
Revenue (TTM)
$0.00
Return On Equity (TTM)
-32.43%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-110.25%

Rapport Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$20.00$0.00
Net Profit-$26.93-$33.76-$19.86-$56.62
Net Profit MarginN/AN/A-99.30%N/A
Income ChangeN/A-25.36%41.17%-185.10%

Rapport Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$78.31-$111.48
Net Profit MarginN/AN/A
Income ChangeN/A-42.36%

About Rapport Therapeutics, Inc.

Rapport Therapeutics Inc is a clinical-stage biotechnology company dedicated to the discovery and development of small-molecule precision medicines for patients with neurological or psychiatric disorders. The company's portfolio of programs from its RAP technology platform includes RAP-219, an investigational small molecule being developed as a therapy for focal onset seizures, primary generalized tonic-clonic seizures, and bipolar mania. Additionally, it has two discovery-stage nicotinic acetylcholine receptor (nAChR) programs stemming from its RAP technology platform: one being developed for the treatment of chronic pain, and the second, being developed for the treatment of hearing disorders. Geographically, the company operates in the United States.

Rapport Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$34.00
$30.60
-8.96%
Sep 2026
$48.88
$33.61
-33.96%
Aug 2026
$40.13
$50.89
+23.94%
Jul 2026
$41.12
$41.06
-1.65%
Jun 2026
$37.98
$41.75
+5.72%
May 2026
$32.84
$39.49
+19.09%
Apr 2026
$31.58
$33.16
+5.40%
Mar 2026
$28.41
$31.46
+8.56%
Feb 2026
$26.99
$28.98
+8.99%
Jan 2026
$30.08
$26.59
-12.40%
Dec 2025
$28.92
$30.36
+2.48%
Nov 2025
$29.13
$29.62
+2.51%

RAPP Share Price FAQs

What is Rapport Therapeutics, Inc. share price today?

chevron-up
Rapport Therapeutics, Inc. share price today is $30.68 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Rapport Therapeutics, Inc. stock?

chevron-up
The 52 week high of Rapport Therapeutics, Inc. stock is $52.93, while the 52 week low is $24.23 as of 10 Oct '26.

What is RAPP's market capitalisation today?

chevron-up
RAPP market capitalisation is $1.19B as of October 10, 2026, at 3:11 pm IST.

What is RAPP's net income for the last quarter?

chevron-up
RAPP's net income for the last quarter is -56.62B USD.

What is the 5 year returns of RAPP?

chevron-up
The 5 year returns of RAPP is 31.88% as on 10 Oct '26.

What is the high & low stock price of RAPP today?

chevron-up
RAPP stock price hit a high of $31.18 and low of $29.68 as of 10 Oct '26.

Can I buy RAPP shares in India?

chevron-up
Yes. You can buy RAPP in India by opening an international trading account.